Allergy Therapeutics

We provide information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with a special focus on allergy vaccination (also known as specific immunotherapy or desensitisation therapy). Allergy vaccination is a successful treatment that deals with the underlying cause of allergies and not just the symptoms! Allergy Therapeutics has a long-term commitment to the development of innovative therapies for allergy treatment and allergy prevention.
Type
Public
HQ
Worthing, GB
Founded
1934
Size (employees)
373 (est)
Allergy Therapeutics was founded in 1934 and is headquartered in Worthing, GB

Allergy Therapeutics Office Locations

Allergy Therapeutics has office in Worthing
Worthing, GB

Allergy Therapeutics Metrics

Allergy Therapeutics Summary

Market capitalization

£149 M

Closing share price

£0.253
Allergy Therapeutics's current market capitalization is £149 M.

Allergy Therapeutics Financials

Allergy Therapeutics's revenue is £43.2 M in FY, 2015 which is 3.04% increase from the previous period.
FY, 2015FY, 2014FY, 2013

Revenue

£43.2 M£42 M£39.3 M

Revenue growth, %

3.0%6.8%

Cost of sales

£12.2 M£12 M£12 M

Gross profit

£31.1 M£30 M£27.3 M

Gross profit Margin, %

71.8%71.5%69.6%

Operating expense total

£30.3 M£28.8 M£26.7 M

Allergy Therapeutics Market Value History

Allergy Therapeutics News

Allergy Therapeutics Company Life

You may also be interested in